Samsung Medical Center
Sigmoid adenocarcinoma treatment cost in the Republic of Korea is influenced by the disease stage and the surgical approach, with a consultation with an oncologist typically ranging from $28 to $100. Primary treatments such as a colectomy run from $16,500 to $29,800. Patients often save approximately 30-50% compared to the US. Most specialized care is concentrated in Seoul, Incheon, and Seongnam.
Typical Sigmoid Adenocarcinoma Treatment Costs in Republic of Korea
Bookimed Expert Insight: High-risk patients benefit from the digital safety systems at Seoul National University Bundang Hospital. For advanced cases, Samsung Medical Center provides multidisciplinary care with Da Vinci robotic technology. Patients seeking scarring reduction should consider Ewha Womans University Medical Center for minimally invasive expertise. Korea University Anam Hospital remains a leader for complex robotic cancer surgeries to minimize infection risks.
| Republic of Korea | Turkey | Austria | |
| Colectomy (large bowel resection) | from $16,500 | from $6,912 | from $22,000 |
| Chemotherapy for breast cancer | from $19,200 | from $1,200 | from $15,000 |
| Radiation therapy for colorectal cancer | - | from $7,000 | from $12,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Sigmoid adenocarcinoma treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Sigmoid adenocarcinoma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Sigmoid adenocarcinoma treatment journey.
The doctor is a leading breast cancer specialist in South Korea and is recognized among the world’s top 100 gastric and breast cancer surgeons. The doctor pioneered breast conserving surgery in South Korea in 1986 and invented a unique stomach cancer surgery that minimizes the risk of gastroesophageal reflux disease. The doctor currently heads the Cancer Center for Women at Ewha Womans University Medical Center and has previously served as President of Konkuk University Hospital and Director of Korea Cancer Center Hospital. The doctor is also an active researcher in breast cancer diagnosis and management.
The doctor is the Head of the Oncology Department, specializing in chemotherapy for lung cancer, head and neck cancer, and esophageal cancer. The focus is on utilizing new clinical drugs to improve treatment outcomes. With extensive experience in oncological therapies, the doctor is at the forefront of cancer treatment advancements.
The doctor is an expert in oncoplastic surgery and breast cancer, with extensive experience from prestigious institutions. The doctor holds an M.D. degree from Seoul National University College of Medicine and an M.S. degree in Surgery from the same institution. Additionally, the doctor earned a B.S. in biological sciences from the Korea Advanced Institute of Science and Technology (KAIST) and a Ph.D. in Surgery from Seoul National University Graduate School.
The doctor is a prominent figure in the field of surgery, holding leadership roles such as Director of the Training and Education Committee at the Korean Surgical Society and Director of the Information Technology Committee at the Korean Society of Coloproctology. The doctor also serves as Director of the Surgical Affairs Board at the Korean Society of Gastroenterology and Vice President of the Korean Association of Robotic Surgeons.
With a robust educational background from Korea University, the doctor has demonstrated surgical expertise internationally, including at the Faculty of Medicine, Chinese University of Hong Kong, and Tan Tock Seng Hospital in Singapore.